Literature DB >> 15643645

Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease?

Giampaolo Perna, Roberto Cogo, Laura Bellodi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15643645     DOI： 10.1002/da.20041

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN： 1091-4269            Impact factor:   6.505


× No keyword cloud information.
  8 in total

1.  Selective serotonin reuptake inhibitors and lung function in the multi-ethnic study of atherosclerosis lung study.

Authors:  Hilary F Armstrong; David Lederer; Gina S Lovasi; Grant Hiura; Corey E Ventetuolo; RGraham Barr
Journal:  Respir Med       Date:  2022-03-12       Impact factor: 4.582

2.  Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.

Authors:  Marc A Meier; Manuel Ottiger; Alaadin Vögeli; Christian Steuer; Luca Bernasconi; Robert Thomann; Mirjam Christ-Crain; Christoph Henzen; Claus Hoess; Werner Zimmerli; Andreas Huber; Beat Mueller; Philipp Schuetz
Journal:  Lung       Date:  2017-04-22       Impact factor: 2.584

3.  Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness.

Authors:  Gareth J Watts; Katherine Clark; Meera Agar; Patricia M Davidson; Christine McDonald; Lawrence T Lam; Dimitar Sajkov; Nicola McCaffrey; Matthew Doogue; Amy P Abernethy; David C Currow
Journal:  BMJ Open       Date:  2016-11-29       Impact factor: 2.692

Review 4.  Is panic disorder a disorder of physical fitness? A heuristic proposal.

Authors:  Giampaolo Perna; Daniela Caldirola
Journal:  F1000Res       Date:  2018-03-08

5.  5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Jaume Lillo; Jordi Camps; Gemma Navarro; Irene Reyes-Resina
Journal:  Front Cell Dev Biol       Date:  2021-04-15

Review 6.  Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.

Authors:  Vitória Segabinazzi Foletto; Taciéli Fagundes da Rosa; Marissa Bolson Serafin; Rosmari Hörner
Journal:  Eur J Clin Pharmacol       Date:  2022-08-09       Impact factor: 3.064

7.  The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.

Authors:  Mohammed Gaber Mohamed Hamed; Radwa Samir Hagag
Journal:  Med Hypotheses       Date:  2020-07-26       Impact factor: 1.538

8.  Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians.

Authors:  Małgorzata Krajnik; Nilay Hepgul; Irene J Higginson; Caroline J Jolley; Andrew Wilcock; Ewa Jassem; Tomasz Bandurski; Silvia Tanzi; Steffen T Simon
Journal:  BMC Pulm Med       Date:  2022-01-19       Impact factor: 3.317
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.